{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:35:59Z","timestamp":1792337759064,"version":"4.4.0"},"reference-count":327,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oral Biology &amp; Medicine"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:p>A wide spectrum of drugs can sometimes give rise to numerous adverse orofacial manifestations, particularly dry mouth, taste disturbances, oral mucosal ulceration, and\/or gingival swelling. There are few relevant randomized double-blind controlled studies in this field, and therefore this paper reviews the data from case reports, small series, and non-peer-reviewed reports of adverse drug reactions affecting the orofacial region (available from a MEDLINE search to April, 2003). The more common and significant adverse orofacial consequences of drug therapy are discussed.<\/jats:p>","DOI":"10.1177\/154411130401500405","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T19:40:32Z","timestamp":1231443632000},"page":"221-239","source":"Crossref","is-referenced-by-count":190,"title":["A\n                    <scp>dverse<\/scp>\n                    D\n                    <scp>rug<\/scp>\n                    R\n                    <scp>eactions in the<\/scp>\n                    O\n                    <scp>rofacial<\/scp>\n                    R\n                    <scp>egion<\/scp>"],"prefix":"10.1177","volume":"15","author":[{"given":"C.","family":"Scully","sequence":"first","affiliation":[{"name":"Eastman Dental Institute for Oral Health Care Sciences, University College, University of London, 256 Gray\u2019s Inn Road, London WC1X 8LD, UK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-V.","family":"Bagan","sequence":"additional","affiliation":[{"name":"Valencia University and Hospital, General Universitario de Valencia, Avenida 3 Cruces, 46014 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"ABDOLLAHI-AND-RADFAR-2003","doi-asserted-by":"publisher","DOI":"10.5005\/jcdp-4-1-10"},{"key":"ACKERMAN-AND-KASBEKAR-1997","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1997.tb03058.x"},{"key":"ADAMS-AND-EISENBRUCH-2000","unstructured":"Adams CE, Eisenbruch M (2000). Depot fluphenazine for schizophrenia.\n                      Cochrane Database Syst Rev\n                      2:CD000307."},{"key":"AGBO-GODEAU-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61045-8"},{"key":"ALLEN-ETAL-2001","unstructured":"Allen CL, Loudon J, Mascarenhas AK (2001). Sanguinaria-related leukoplakia: epidemiologic and clinicopathologic features of a recently described entity. Gen Dent 49:608\u2013614."},{"key":"ANTTILA-AND-LEINONEN-2001","doi-asserted-by":"crossref","unstructured":"Anttila SA, Leinonen EV (2001). A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7:249\u2013264.","DOI":"10.1111\/j.1527-3458.2001.tb00198.x"},{"key":"ATKINSON-ETAL-1989","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-2358.1989.tb00398.x"},{"key":"AXELL-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1986.tb01276.x"},{"key":"AYANGCO-AND-ROGERS-2003","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00062-1"},{"key":"BELL-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117244"},{"key":"BERGDAHL-AND-BERGDAHL-2000","doi-asserted-by":"publisher","DOI":"10.1177\/00220345000790090301"},{"key":"BILINSKA-PIETRASZEK-ETAL-2001","unstructured":"Bilinska-Pietraszek E, Namyslowski G, Mrowka-Kata K, Scierski W, Aniol-Borkowska M (2001). [A case of tongue neoplasm in a 15-year old patient treated with immunosuppressants for renal insufficiency]. Otolaryngol Pol 55:95\u201397."},{"key":"BIRCHER-ETAL-1993","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1993.tb03568.x"},{"key":"BOLEWSKA-ETAL-1990","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(90)90178-U"},{"key":"BOOZER-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802023"},{"key":"BOSCH-ETAL-1985","unstructured":"Bosch JA, Valdes M, Oristrell J, Pigrau C, Ordi J (1985). Oxyphenbutazone-induced sialadenitis, intrahepatic cholestasis and pancreatitis. Acta Gastroenterol Belg 48:529\u2013530."},{"key":"BOULINGUEZ-ETAL-1997","unstructured":"Boulinguez S, Bedane C, Bouyssou-Gauthier ML, Cornee-Leplat I, Truong E, Bonnetblanc JM (1997). [Giant buccal aphthosis caused by nicorandil]. Presse Med 26(12):558."},{"key":"BOULINGUEZ-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03898.x"},{"key":"BOWMAN-ETAL-1988","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(88)90163-6"},{"key":"BOYD-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Boyd LD, Dwyer JT, Papas A (1997). Nutritional implications of xerostomia and rampant caries caused by serotonin reuptake inhibitors: a case study. Nutr Rev 55:362\u2013368.","DOI":"10.1111\/j.1753-4887.1997.tb01562.x"},{"key":"BRATEL-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1016\/0300-5712(95)00004-6"},{"key":"BRAY-2001","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011808701117"},{"key":"BRENNER-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80273-3"},{"key":"BRENNER-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(98)00010-8"},{"key":"BRITISH-NATIONAL-FORMULARY-2002","unstructured":"British National Formulary (2002). Antituberculous drugs. In: British National Forumulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, pp. 290\u2013291."},{"key":"BROWN-ETAL-1993","unstructured":"Brown RS, Hays GL, Flaitz CM (1993). Treatment of gold salt-induced oral lichen planus: report of a case. Cutis 51:183\u2013185."},{"key":"BRUERA-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050261"},{"key":"BUCKNALL-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.56.3.278"},{"key":"BURLINGAME-AND-RUBIN-1996","doi-asserted-by":"publisher","DOI":"10.1007\/BF00351164"},{"key":"BUSTO-ETAL-2001","unstructured":"Busto UE, Sproule BA, Knight K, Herrmann N (2001). Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 8:213\u2013221."},{"key":"CASABURI-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.5.1294"},{"key":"CEBECI-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1996.67.11.1201"},{"key":"CHACKO-ETAL-1987","unstructured":"Chacko RC, Marsh BJ, Marmion J, Dworkin RJ, Telschow R (1987). Lithium side effects in elderly bipolar outpatients. Hillside J Clin Psychiatry 9:79\u201388."},{"key":"CHAU-ETAL-1984","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(84)90331-1"},{"key":"CHI-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1159\/000055306"},{"key":"CHIMENES-1971","unstructured":"Chimenes H (1971). [Phenylbutazone derivatives and pathology of the salivary glands]. Presse Med 79(2):54."},{"key":"CHRISTODOULOU-ETAL-1977","unstructured":"Christodoulou GN, Siafakas A, Rinieris PM (1977). Side-effects of lithium. Acta Psychiatr Belg 77:260\u2013266."},{"key":"CLEMETT-AND-JARVIS-2001","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200118040-00005"},{"key":"COHEN-AND-BANKS-1966","doi-asserted-by":"crossref","unstructured":"Cohen L, Banks P (1966). Salivary gland enlargement and phenylbutazone. Br Med J 5500:1420.","DOI":"10.1136\/bmj.1.5500.1420-a"},{"key":"COLVARD-ETAL-1986","unstructured":"Colvard MD, Nadimi H, Gargiulo AV (1986). Ativan (lorazepam) induced lichenoid reaction of the human attached gingiva: case report. Periodontal Case Rep 8:69\u201370."},{"key":"COMLEY-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1080\/000486700285"},{"key":"CONKLIN-AND-BLASBERG-1987","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30709-5"},{"key":"CONSROE-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.3109\/00207458608985678"},{"key":"CONTI-AND-PINDER-1979","doi-asserted-by":"publisher","DOI":"10.1177\/030006057900700405"},{"key":"CORONE-ETAL-1987","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(87)80110-8"},{"key":"COTLER-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2000.00215.x"},{"key":"CRIBIER-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02107.x"},{"key":"DAMM-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(99)70296-9"},{"key":"DAVIES-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00318-9"},{"key":"DAVIS-AND-FAULDS-1996","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199652050-00007"},{"key":"DESRUELLES-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02198.x"},{"key":"DETKE-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0407"},{"key":"DI-GIOVANNI-1990","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.1990.tb00785.x"},{"key":"DICKSTEIN-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(00)00319-3"},{"key":"DIEDERICH-AND-GOETZ-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(05)70370-4"},{"key":"DINSDALE-AND-WALKER-1966","unstructured":"Dinsdale RC, Walker AE (1966). Amiphenazole sensitivity with oral ulceration. Br Dent J 121:460\u2013462."},{"key":"DODD-ETAL-1992","doi-asserted-by":"crossref","unstructured":"Dodd CL, Greenspan D, Westenhouse JL, Katz MH (1992). Xerostomia associated with didanosine. Lancet 340(8822):790.","DOI":"10.1016\/0140-6736(92)92330-I"},{"key":"DOLBERG-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1097-z"},{"key":"DOWNHAM-1978","doi-asserted-by":"crossref","unstructured":"Downham TF III (1978). Spironolactone-induced lichen planus. J Am Med Assoc 240(11):1138.","DOI":"10.1001\/jama.1978.03290110036005"},{"key":"DREIZEN-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1992.11701299"},{"key":"DUGGAN-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Duggan L, Fenton M, Dardennes RM, El Dosoky A, Indran S (2000). Olanzapine for schizophrenia.\n                      Cochrane Database Syst Rev\n                      (2):CD001359.","DOI":"10.1002\/14651858.CD001359"},{"key":"EBO-AND-STEVENS-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1997.tb01007.x"},{"key":"EISEN-1993","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70082-5"},{"key":"ELIE-AND-LAMONTAGNE-1984","doi-asserted-by":"crossref","unstructured":"Elie R, Lamontagne Y (1984). Alprazolam and diazepam in the treatment of generalized anxiety. J Clin Psychopharmacol 4:125\u2013129.","DOI":"10.1097\/00004714-198406000-00002"},{"key":"ELLINGROD-AND-PERRY-1994","doi-asserted-by":"crossref","unstructured":"Ellingrod VL, Perry PJ (1994). Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 51:3033\u20133046.","DOI":"10.1093\/ajhp\/51.24.3033"},{"key":"ELLIS-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR (1993). Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Lancet 341:1102\u20131103.","DOI":"10.1016\/0140-6736(93)92470-E"},{"key":"EVERSOLE-AND-RINGER-1984","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(84)90155-5"},{"key":"FATTORE-ETAL-1991","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.1991.tb00828.x"},{"key":"FEIGHNER-1999","unstructured":"Feighner JP (1999). Mechanism of action of antidepressant medications. J Clin Psychiatry 60(Suppl 4):4\u201311."},{"key":"FEIGHNER-AND-OVERO-1999","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1204"},{"key":"FEMIANO-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1054\/ijom.2002.0276"},{"key":"FEMIANO-ETAL-2003","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2003.29"},{"key":"FICARRA-ETAL-1990","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(90)90014-J"},{"key":"FIELD-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-2358.2001.00021.x"},{"key":"FINNE-ETAL-1982","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9785(82)80073-2"},{"key":"FIRTH-AND-READE-1989","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(89)90300-9"},{"key":"FLAGEUL-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.1159\/000249262"},{"key":"FORD-ETAL-1994","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.11.2115"},{"key":"FOX-1998","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09641.x"},{"key":"FREYE-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Freye E, Baranowski J, Latasch L (2001). Dose-related effects of controlled release dihydrocodeine on oro-cecal transit and pupillary light reflex. A study in human volunteers. Arzneimittelforschung 51:60\u201366.","DOI":"10.1055\/s-0031-1300003"},{"key":"FRIEDLANDER-AND-BIRCH-1990","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.1990.tb00782.x"},{"key":"GABB-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1996.tb00624.x"},{"key":"GALL-ETAL-1986","unstructured":"Gall Y, Guillet G, Leroy JP, Masse R, Guillet MH (1986). [Bullae and urticaria-like lesions of allergic vasculitis with immunomarkers of the bullous pemphigoid type during treatment with D-penicillamine]. Ann Dermatol Venereol 113:55\u201358."},{"key":"GANGE-ETAL-1976","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1976.tb00849.x"},{"key":"GATTONI-ETAL-1991","unstructured":"Gattoni F, Pozzato C, Padovese P, Rizzi AM, Brancaccio D, Uslenghi C (1991). [Salivary gland enlargement caused by intravenous iodinated contrast medium. Description of a case]. Radiol Med (Torino) 81:162\u2013163."},{"key":"GELENBERG-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.23.3082"},{"key":"GIANSANTI-ETAL-1971","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(71)90035-1"},{"key":"GIBSON-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Gibson LE, van Hale HM, Schroeter AL (1986). Direct immunofluorescence for the study of cutaneous drug eruptions. Acta Derm Venereol 66:39\u201344.","DOI":"10.2340\/00015555663944"},{"key":"GLASS-1989","unstructured":"Glass BJ (1989). Drug-induced xerostomia as a cause of glossodynia. Ear Nose Throat J 68(10):776\u2013781."},{"key":"GLOVER-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Glover J, Dibble S, Miaskowski C, Geibert R (1995). Changes in taste associated with intravenous administration of pentamidine. J Assoc Nurses AIDS Care 6:43\u201348.","DOI":"10.1016\/S1055-3290(05)80029-9"},{"key":"GOLDBERG-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00836.x"},{"key":"GONZALEZ-MOLES-AND-BAGAN-SEBASTIAN-2000","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2000.291006.x"},{"key":"GOODMAN-ETAL-1983","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.6.394"},{"key":"GORDON-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500311"},{"key":"GRECO-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Greco S, Mazzaglia G, Caputi AP, Pagliaro L (1997). Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics. Ann Pharmacother 31:1548.","DOI":"10.1177\/106002809703101220"},{"key":"GREENBERG-ETAL-1987","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.2.280"},{"key":"GREENWOOD-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4809668"},{"key":"GREGORIOU-ETAL-1996","unstructured":"Gregoriou AP, Schneider PE, Shaw PR (1996). Phenobarbital-induced gingival overgrowth? Report of two cases and complications in management. ASDC J Dent Child 63:408\u2013413."},{"key":"GRIFFIN-1992","unstructured":"Griffin JP (1992). Drug-induced disorders of taste. Adverse Drug React Toxicol Rev 11:229\u2013239."},{"key":"GROTENHERMEN-1999","doi-asserted-by":"crossref","unstructured":"Grotenhermen F (1999). [The effects of cannabis and THC]. Forsch Komplementarmed 6(Suppl 3):7\u201311.","DOI":"10.1159\/000057149"},{"key":"GUASTI-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.5.1146"},{"key":"GWALTNEY-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.4.656"},{"key":"HAAGSMA-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)81171-5"},{"key":"HAAS-AND-LENNON-1995","unstructured":"Haas DA, Lennon D (1995). A 21 year retrospective study of reports of paresthesia following local anesthetic administration. J Canad Dent Assoc 61:319\u2013330."},{"key":"HAKALA-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.3.177"},{"key":"HALPERN-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Halpern SM, Todd PM, Kirby JD (1996). Loss of taste associated with isotretinoin. Br J Dermatol 134:378.","DOI":"10.1111\/j.1365-2133.1996.tb07641.x"},{"key":"HANSEN-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/23.4.567"},{"key":"HATLEBAKK-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509101606"},{"key":"HAY-SMITH-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Hay-Smith J, Herbison P, Ellis G, Moore K (2002). Anticholinergic drugs versus placebo for overactive bladder syndrome in adults (Cochrane Review).\n                      Cochrane Database Syst Rev\n                      (3):CD003781.","DOI":"10.1002\/14651858.CD003781"},{"key":"HEALY-AND-THORNHILL-1995","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1995.tb01129.x"},{"key":"HENKIN-1994","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199411050-00004"},{"key":"HENNES-ETAL-1984","doi-asserted-by":"publisher","DOI":"10.1007\/BF00414230"},{"key":"HENRIKSSON-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1995.tb00150.x"},{"key":"HERLOFSON-AND-BARKVOLL-1994","doi-asserted-by":"publisher","DOI":"10.3109\/00016359409029036"},{"key":"HERMAN-ETAL-1974","unstructured":"Herman I, Schwartz Y, Bassan H (1974). [Primary cardiac involvement and painful salivary gland enlargement due to phenylbutazone]. Harefuah 86:246\u2013247."},{"key":"HERNANDEZ-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2001.116152"},{"key":"HERNANDEZ-ETAL-2003","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(02)00009-X"},{"key":"HERTZ-ETAL-1980","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1980.0235"},{"key":"HEYMANN-2000","unstructured":"Heymann WR (2000). Psychotropic agent-induced black hairy tongue. Cutis 66:25\u201326."},{"key":"HIETANEN-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Hietanen J, Pihlman K, Forstrom L, Linder E, Reunala T (1987). No evidence of hypersensitivity to dental restorative metals in oral lichen planus. Scand J Dent Res 95:320\u2013327.","DOI":"10.1111\/j.1600-0722.1987.tb01848.x"},{"key":"HOGAN-ETAL-1985","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(85)70166-1"},{"key":"HOLMSTRUP-1991","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1991.tb00878.x"},{"key":"HSI-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200001000-00012"},{"key":"HUNTER-AND-WILSON-1995","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(95)00079-5"},{"key":"IBBOTSON-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb16224.x"},{"key":"ILIA-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Ilia R, Aizenberg O, Moshe G (1991). Salivary gland enlargement following renografin injection may be secondary to hypersensitivity. Cathet Cardiovasc Diagn 23:69\u201370.","DOI":"10.1002\/ccd.1810230123"},{"key":"INGAFOU-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(97)90066-4"},{"key":"JABER-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<333::AID-IJC4>3.0.CO;2-P"},{"key":"JACKSON-AND-BABICH-1997","unstructured":"Jackson C, Babich S (1997). Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report. NY State Dent J 63:46\u201348."},{"key":"JACQUETIN-AND-WYNDAELE-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00561-3"},{"key":"JAMES-ETAL-1987","doi-asserted-by":"publisher","DOI":"10.1016\/0266-4356(87)90139-2"},{"key":"JAMESON-ETAL-1990","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.1990.tb00012.x"},{"key":"JIMENEZ-JIMENEZ-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199716030-00004"},{"key":"JOHNSTON-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1080\/14622200125680"},{"key":"JOLLY-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4805877"},{"key":"KAISER-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199807000-00007"},{"key":"KAPLAN-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70057-M"},{"key":"KATZ-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1997.tb00488.x"},{"key":"KAUFMAN-ETAL-1977","unstructured":"Kaufman E, Garfunkel AA, Tzukert A (1977). [Acute sialadenitis due to butazolidin]. Harefuah 93:405\u2013406."},{"key":"KAVIANI-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200108000-00007"},{"key":"KAWAGUCHI-AND-YAMAGISHI-1995","doi-asserted-by":"publisher","DOI":"10.1254\/fpj.105.295"},{"key":"KEDICI-ETAL-1995","unstructured":"Kedici PS, Memikoglu MM, Kansu G, Isimer A, Gunhan O (1995). Case report: ionisation tendency of a base metal alloy in the oral environment. Eur J Prosthodont Restor Dent 3:231\u2013234."},{"key":"KEOGH-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2002.126889"},{"key":"KING-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504203321602"},{"key":"KIRBY-ETAL-1980","doi-asserted-by":"publisher","DOI":"10.1177\/014107688007300311"},{"key":"KNULST-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02723.x"},{"key":"KORMAN-ETAL-1991","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12464471"},{"key":"KUECHLE-ETAL-1994","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70015-X"},{"key":"KUTTAN-ETAL-2001","unstructured":"Kuttan NA, Narayana N, Moghadam BK (2001). Desquamative stomatitis associated with routine use of oral health care products. Gen Dent 49:596\u2013602."},{"key":"LADER-1996","unstructured":"Lader MH (1996). Tolerability and safety: essentials in antidepressant pharmacotherapy. J Clin Psychiatry 57(Suppl 2):39\u201344."},{"key":"LAEIJENDECKER-AND-VAN-JOOST-1994","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70018-4"},{"key":"LAINE-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)21861-X"},{"key":"LAINE-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0964-1955(92)90040-8"},{"key":"LAMEY-ETAL-1990","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(90)90116-A"},{"key":"LAMEY-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(05)80072-1"},{"key":"LAPOSTOLLE-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00932-6"},{"key":"LASKARIS-AND-NICOLIS-1980","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(80)90419-3"},{"key":"LASKARIS-AND-SATRIANO-1993","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(93)90164-8"},{"key":"LAYTON-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124090-00005"},{"key":"LEE-AND-LEE-1997","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1997.00411.x"},{"key":"LIND-AND-HURLEN-1988","doi-asserted-by":"crossref","unstructured":"Lind PO, Hurlen B (1988). Desquamative gingivitis responding to treatment with tetracycline: a pilot study. Scand J Dent Res 96:232\u2013234.","DOI":"10.1111\/j.1600-0722.1988.tb01549.x"},{"key":"LIND-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Lind PO, Hurlen B, Lyberg T, Aas E (1986). Amalgam-related oral lichenoid reaction. Scand J Dent Res 94:448\u2013451.","DOI":"10.1111\/j.1600-0722.1986.tb01786.x"},{"key":"LOESCHE-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1995.tb05815.x"},{"key":"LOMBARDI-ETAL-1993","doi-asserted-by":"publisher","DOI":"10.1159\/000247321"},{"key":"LYELL-1979","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1979.tb03571.x"},{"key":"MADERSBACHER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Madersbacher H, Halaska M, Voigt R, Alloussi S, Hofner K (1999). A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence. BJU Int 84:646\u2013651.","DOI":"10.1046\/j.1464-410x.1999.00251.x"},{"key":"MADINIER-ETAL-1997","unstructured":"Madinier I, Jehl-Pietri C, Monteil RA (1997). [Drug-induced xerostomia]. Ann Med Interne\n                      (Paris)\n                      148:398\u2013405."},{"key":"MAHBOOB-AND-HAROON-1998","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00451.x"},{"key":"MAILLEFERT-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(97)90315-2"},{"key":"MANDEL-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1053\/joms.2001.23400"},{"key":"MANDEL-AND-MANDEL-2003","doi-asserted-by":"publisher","DOI":"10.1089\/105072503321582060"},{"key":"MANGRELLA-ETAL-1998","unstructured":"Mangrella M, Motola G, Russo F, Mazzeo F, Giassa T, Falcone G,\n                      et al.\n                      (1998). [Hospital intensive monitoring of adverse reactions of ACE inhibitors]. Minerva Med 89:91\u201397."},{"key":"MANOR-ETAL-1981","unstructured":"Manor A, Sperling I, Buchner A (1981). Gingival pigmentation associated with antimalarial drugs. Refuat Hapeh Vehashinayim 28(4):13\u201316."},{"key":"MARKITZIU-ETAL-1986","doi-asserted-by":"crossref","unstructured":"Markitziu A, Katz J, Pisanty S (1986). Lichenoid lesions of oral mucosa associated with ketoconazole. Mykosen 29:317\u2013322.","DOI":"10.1111\/j.1439-0507.1986.tb03792.x"},{"key":"MARQUART-ELBAZ-ETAL-1999","unstructured":"Marquart-Elbaz C, Lipsker D, Grosshans E, Cribier B (1999). [Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects]. Ann Dermatol Venereol 126:587\u2013590."},{"key":"MARSHALL-AND-BARTOLD-1998","doi-asserted-by":"crossref","unstructured":"Marshall RI, Bartold PM (1998). Medication induced gingival overgrowth. Oral Dis 4:130\u2013151.","DOI":"10.1111\/j.1601-0825.1998.tb00269.x"},{"key":"MASCARENHAS-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200111000-00024"},{"key":"MASCARENHAS-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-7325.2002.tb03437.x"},{"key":"MATTILA-AND-PAAKKARI-1999","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050600"},{"key":"MATTINGLY-ETAL-1993","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90139-U"},{"key":"MATZ-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1159\/000245685"},{"key":"MCALLAN-AND-ADKINS-1986","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.1986.tb02976.x"},{"key":"MCCARRON-1984","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198400065-00025"},{"key":"MCCARTAN-AND-MCCREARY-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00376.x"},{"key":"MCCARTHY-AND-SKILLINGS-1991","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1991.tb00942.x"},{"key":"MCCARTHY-AND-SKILLINGS-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90063-V"},{"key":"MCCARTHY-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(98)00068-2"},{"key":"MCQUEEN-AND-BEHAN-1982","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-198204000-00010"},{"key":"MEURMAN-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(98)90152-4"},{"key":"MEYERS-ETAL-1976","unstructured":"Meyers AD, Barker C, Grossman R, Potsic WP, Jafek BW (1976). Kaposi\u2019s sarcoma of the oropharynx following renal transplantation. Trans Am Acad Ophthalmol Otolaryngol 82:560\u2013562."},{"key":"MEYERSON-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(05)80279-3"},{"key":"MILLER-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90016-J"},{"key":"MILOSEVIC-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Milosevic A, Agrawal N, Redfearn P, Mair L (1999). The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymethamphetamine). Community Dent Oral Epidemiol 27:283\u2013287.","DOI":"10.1111\/j.1600-0528.1999.tb02022.x"},{"key":"MIRBOD-AND-AHING-2000","unstructured":"Mirbod SM, Ahing SI (2000). Tobacco-associated lesions of the oral cavity: part I. Nonmalignant lesions. J Can Dent Assoc 66:252\u2013256."},{"key":"MOBACKEN-ETAL-1984","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1984.tb00053.x"},{"key":"MONTONER-ETAL-1990","unstructured":"Montoner F, Ortiz M, Capella D, Ruiz J (1990). [Aphthous stomatitis due to captopril]. Aten Primaria 7:79."},{"key":"MULLEN-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)89080-3"},{"key":"MURRAY-BRUCE-1966","doi-asserted-by":"crossref","unstructured":"Murray-Bruce DJ (1966). Salivary gland enlargement and phenylbutazone. Br Med J 5503:1599\u20131600.","DOI":"10.1136\/bmj.1.5503.1599-c"},{"key":"NAGLER-1998","unstructured":"Nagler RM (1998). Effects of radiotherapy and chemotherapeutic cytokines on a human salivary cell line. Anticancer Res 18(1A):309\u2013314."},{"key":"NARHI-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199915020-00004"},{"key":"NEDERFORS-1996","unstructured":"Nederfors T (1996). Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J 116(Suppl):1\u201370."},{"key":"NICHOLLS-ETAL-1981","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-5-659"},{"key":"NOGUCHI-ETAL-1998","unstructured":"Noguchi K, Masuda M, Noguchi S, Kubota Y, Hosaka M, Senga Y,\n                      et al.\n                      (1998). [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence]. Hinyokika Kiyo 44:687\u2013693."},{"key":"OGUNWANDE-1989","unstructured":"Ogunwande SA (1989). Halitosis and abuse of antibiotics. Report of a case. Ceylon Med J 34:131\u2013133."},{"key":"OIKARINEN-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.3109\/00016359509006003"},{"key":"ONG-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2000.00445.x"},{"key":"OSTMAN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Ostman PO, Anneroth G, Skoglund A (1994). Oral lichen planus lesions in contact with amalgam fillings: a clinical, histologic, and immunohistochemical study. Scand J Dent Res 102:172\u2013179.","DOI":"10.1111\/j.1600-0722.1994.tb01175.x"},{"key":"PAJUKOSKI-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2001.118478"},{"key":"PALMER-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04492.x"},{"key":"PARKER-1975","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561562"},{"key":"PARRY-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4809127"},{"key":"PENNEYS-ETAL-1974","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1974.01630030032006"},{"key":"PERNU-ETAL-1989","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1989.tb01576.x"},{"key":"PEROUTKA-ETAL-1988","unstructured":"Peroutka SJ, Newman H, Harris H (1988). Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273\u2013277."},{"key":"PERSSON-ETAL-1991","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(91)90187-H"},{"key":"PINDBORG-ETAL-1980","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800501)45:9<2330::AID-CNCR2820450916>3.0.CO;2-R"},{"key":"POMARA-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00175-0"},{"key":"PORTER-ETAL-1990","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(90)90179-V"},{"key":"POTGIETER-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Potgieter GE, Groenewoud G, Jordaan PJ, Hundt HK, Schall R, Kummer M,\n                      et al.\n                      (2002). Pharmacokinetics of pipamperone from three different tablet formulations. Arzneimittelforschung 52:430\u2013434.","DOI":"10.1055\/s-0031-1299910"},{"key":"POTTS-ETAL-1987","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(87)90029-6"},{"key":"PRADALIER-ETAL-1982","unstructured":"Pradalier A, Dry J, Baron JF (1982). [Aphthoid stomatitis induced by labetalol]. Therapie 37:695\u2013697."},{"key":"PRICE-AND-VENABLES-1995","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199512040-00008"},{"key":"QUNIBI-ETAL-1988","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(88)80142-2"},{"key":"RAMADAN-1969","unstructured":"Ramadan AE (1969). The association of black hairy tongue with toothpastes containing neomycin. Report of two cases. Egypt Dent J 15:253\u2013256."},{"key":"RASMUSSEN-ETAL-1989","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1989.tb00031.x"},{"key":"RAUT-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2000.107446"},{"key":"RAVINDRAN-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0305"},{"key":"READ-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1995.tb00580.x"},{"key":"REES-AND-GIBSON-1997","doi-asserted-by":"crossref","unstructured":"Rees SR, Gibson J (1997). Angioedema and swellings of the orofacial region. Oral Dis 3:39\u201342.","DOI":"10.1111\/j.1601-0825.1997.tb00007.x"},{"key":"REICHART-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1997.tb00356.x"},{"key":"REID-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(01)02239-7"},{"key":"RICH-1996","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.1996.09.83"},{"key":"RICHTER-1999","unstructured":"Richter WO (1999). [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine]. MMW Fortschr Med 141(49\u201350):32\u201336."},{"key":"ROBERTS-AND-MARKS-1981","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1981.01650050029015"},{"key":"ROBERTSON-AND-WRAY-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90380-9"},{"key":"ROGER-ETAL-1998","unstructured":"Roger M, Gerard D, Leger JM (1998). [Value of tiapride for agitation in the elderly. Review of published studies]. Encephale 24:462\u2013468."},{"key":"ROUJEAU-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1997.tb02524.x"},{"key":"ROUSSEL-ETAL-1998","unstructured":"Roussel S, Courville P, Peron JM, Delcampe P, Metayer J (1998). [Oral aphthae induced by nicorandil. Anatomopathologic aspects. A propos of a case]. Rev Stomatol Chir Maxillofac 99:207\u2013209."},{"key":"RUOCCO-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1159\/000246417"},{"key":"RUSHTON-1977","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1977.tb00053.x"},{"key":"SABROE-AND-BLACK-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1997.tb14887.x"},{"key":"SAVINO-AND-HAUSHALTER-1992","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202601109"},{"key":"SCHACHTER-1999","unstructured":"Schachter M (1999). Moxonidine: a review of safety and tolerability after seven years of clinical experience. J Hypertens 17(Suppl 3):S37\u2013S39."},{"key":"SCHATZBERG-2000","unstructured":"Schatzberg AF (2000). Clinical efficacy of reboxetine in major depression. J Clin Psychiatry 61(Suppl 10):31\u201338."},{"key":"SCHIER-ETAL-2002","unstructured":"Schier JG, Hoffman RS, Nelson LS (2002). Desiccant-induced gastrointestinal burns in a child. Vet Hum Toxicol 44:343\u2013344."},{"key":"SCHUBERT-1991","unstructured":"Schubert MM (1991). Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent 1:384\u2013397."},{"key":"SCHUBERT-ETAL-1993","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1993.tb01069.x"},{"key":"SCIUBBA-1995","doi-asserted-by":"publisher","DOI":"10.1177\/10454411950060020401"},{"key":"SCOTT-1998","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00296.x"},{"key":"SCOTT-AND-PERRY-2000","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200060010-00008"},{"key":"SCULLY-1992","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4807902"},{"key":"SCULLY-2003","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2003.03967.x"},{"key":"SCULLY-AND-CHALLACOMBE-2002","doi-asserted-by":"publisher","DOI":"10.1177\/154411130201300504"},{"key":"SCULLY-AND-DIZ-2001","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2001.70401.x"},{"key":"SCULLY-AND-PORTER-1997","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(97)80021-1"},{"key":"SCULLY-ETAL-1994","doi-asserted-by":"publisher","DOI":"10.1177\/10454411940050020101"},{"key":"SCULLY-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.1177\/10454411980090010501"},{"key":"SCULLY-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051X.1999.260406.x"},{"key":"SCULLY-ETAL-2000","unstructured":"Scully C, Bagan J, Eisen D, Porter S, Rogers R (2000). Dermatology of the lips. Oxford: Isis Medical Media."},{"key":"SEEDAT-1979","doi-asserted-by":"crossref","unstructured":"Seedat YK (1979). Aphthous ulcers of mouth from captopril. Lancet 2:1297\u20131298.","DOI":"10.1016\/S0140-6736(79)92304-3"},{"key":"SEKINE-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050676"},{"key":"SEYMOUR-AND-JACOBS-1992","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1992.tb01140.x"},{"key":"SEYMOUR-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1997.tb00219.x"},{"key":"SHAPIRO-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90146-4"},{"key":"SHOTTS-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(99)70165-4"},{"key":"SHRIVASTAVA-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Shrivastava RK, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J,\n                      et al.\n                      (1994). Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 14:322\u2013329.","DOI":"10.1097\/00004714-199410000-00006"},{"key":"SHUTTLEWORTH-ETAL-1985","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1985.tb00589.x"},{"key":"SIEGEL-AND-BALCIUNAS-1991","doi-asserted-by":"crossref","unstructured":"Siegel MA, Balciunas BA (1991). Medication can induce severe ulcerations. J Am Dent Assoc 122:75\u201377.","DOI":"10.14219\/jada.archive.1991.0284"},{"key":"SKOGLUND-AND-EGELRUD-1991","doi-asserted-by":"crossref","unstructured":"Skoglund A, Egelrud T (1991). Hypersensitivity reactions to dental materials in patients with lichenoid oral mucosal lesions and in patients with burning mouth syndrome. Scand J Dent Res 99:320\u2013328.","DOI":"10.1111\/j.1600-0722.1991.tb01035.x"},{"key":"SMART-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4808663"},{"key":"SMITH-AND-BURTNER-1994","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-4505.1994.tb01112.x"},{"key":"SPROULE-ETAL-1999","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<851::AID-GPS33>3.0.CO;2-L"},{"key":"SREEBNY-AND-SCHWARTZ-1997","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-2358.1997.00033.x"},{"key":"SRISURAPANONT-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Srisurapanont M, Disayavanish C, Taimkaew K (2000). Quetiapine for schizophrenia.\n                      Cochrane Database Syst Rev\n                      (2):CD000967.","DOI":"10.1002\/14651858.CD000967"},{"key":"STRECKFUS-1995","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1995.0277"},{"key":"STRICKER-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.04105.x"},{"key":"SUZUKI-ETAL-1983","unstructured":"Suzuki N, Saito K, Shiota T, Akizuki H, Michiwaki Y, Ohno K,\n                      et al.\n                      (1983). [Fundamental and clinical studies of long acting amoxicillin granules in oral and maxillofacial surgery infections]. Jpn J Antibiot 36:452\u2013463."},{"key":"SYRJANEN-AND-SYRJANEN-1979","unstructured":"Syrjanen SM, Syrjanen KJ (1979). Hyperplastic gingivitis in a child receiving sodium valproate treatment. Proc Finn Dent Soc 75:95\u201398."},{"key":"TARICCO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Taricco M, Adone R, Pagliacci C, Telaro E (2000). Pharmacological interventions for spasticity following spinal cord injury.\n                      Cochrane Database Syst Rev\n                      (2):CD001131.","DOI":"10.1002\/14651858.CD001131"},{"key":"TEARE-ETAL-1995","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093266"},{"key":"THOMASON-ETAL-1996","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1996.tb00559.x"},{"key":"THOMSON-ETAL-2000","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-7325.2000.tb03286.x"},{"key":"THOMSON-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0528.2002.300309.x"},{"key":"TIMMS-ETAL-1988","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100105997"},{"key":"TOHEN-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.1.62"},{"key":"TOREN-ETAL-1996","unstructured":"Toren A, Ackerstein A, Gazit D, Or R, Raveh D, Kupolovicz U,\n                      et al.\n                      (1996). Oral tuberculosis following autologous bone marrow transplantation for Hodgkin\u2019s disease with interleukin-2 and alpha-interferon immunotherapy. Bone Marrow Transplant 18:209\u2013210."},{"key":"TORRELO-ETAL-1990","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80920-6"},{"key":"TORRESANI-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Torresani C, Nannini R, Bondi A, Guadagni M, Manara GC (1994). Erosive oral lichen planus due to sensitization to cobalt chloride. Clin Exp Dermatol 19:535\u2013536.","DOI":"10.1111\/j.1365-2230.1994.tb01269.x"},{"key":"TRIANTOS-ETAL-1997","doi-asserted-by":"publisher","DOI":"10.1086\/516131"},{"key":"TRINDADE-ETAL-1998","unstructured":"Trindade E, Menon D, Topfer LA, Coloma C (1998). Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 159:1245\u20131252."},{"key":"TROY-ETAL-1981","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(81)70055-0"},{"key":"TUR-AND-BRENNER-1998","doi-asserted-by":"crossref","unstructured":"Tur E, Brenner S (1998). Diet and pemphigus. In pursuit of exogenous factors in pemphigus and\n                      fogo selvagem\n                      . Arch Dermatol 134:1406\u20131410.","DOI":"10.1001\/archderm.134.11.1406"},{"key":"ULMER-AND-GARVEY-1992","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202601012"},{"key":"VALENTINE-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92791-D"},{"key":"VALSECCHI-AND-CAINELLI-1992","doi-asserted-by":"crossref","unstructured":"Valsecchi R, Cainelli T (1992). Gingival hyperplasia induced by erythromycin. Acta Derm Venereol 72:157.","DOI":"10.2340\/0001555572157"},{"key":"VAN-DEN-HAUTE-ETAL-1989","doi-asserted-by":"publisher","DOI":"10.1159\/000248091"},{"key":"VAN-DIS-AND-PARKS-1995","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(05)80302-6"},{"key":"VAN-GELDER-ETAL-2003","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000056639.74982.F9"},{"key":"VAN-JOOST-1974","doi-asserted-by":"crossref","unstructured":"van Joost T (1974). Incidence of circulating antibodies reactive with basal cells of skin in drug reactions. Acta Derm Venereol 54:183\u2013187.","DOI":"10.2340\/0001555554183187"},{"key":"VARGA-AND-TYLDESLEY-1991","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4807594"},{"key":"VASILE-AND-STEINGARD-1995","unstructured":"Vasile JS, Steingard S (1995). Clozapine and the development of salivary gland swelling: a case study. J Clin Psychiatry 56:511\u2013513."},{"key":"VASSILEVA-1998","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(98)00008-X"},{"key":"VELTHUIS-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Velthuis PJ, Hendrikse JC, Nefkens JJ (1985). Combined features of pemphigus and pemphigoid induced by penicillamine. Br J Dermatol 112:615\u2013619.","DOI":"10.1111\/j.1365-2133.1985.tb15273.x"},{"key":"VERSI-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Versi E, Appell R, Mobley D, Patton W, Saltzstein D (2000). Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group. Obstet Gynecol 95:718\u2013721.","DOI":"10.1097\/00006250-200005000-00017"},{"key":"VERSIANI-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0107"},{"key":"VISSINK-ETAL-1992","unstructured":"Vissink A, van Nieuw Amerongen A, Wesseling H, and \u2019s-Gravenmade EJ (1992). [Dry mouth; possible cause\u2014pharmaceuticals]. Ned Tijdschr Tandheelkd 99(3):103\u2013112."},{"key":"VLASSES-ETAL-1982","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6330.1672"},{"key":"VLEEMING-ETAL-1998","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818030-00003"},{"key":"WADWORTH-AND-MCTAVISH-1993","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199303050-00006"},{"key":"WAHLBECK-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Wahlbeck K, Cheine M, Essali MA (2000). Clozapine versus typical neuroleptic medication for schizophrenia.\n                      Cochrane Database Syst Rev\n                      (2):CD000059.","DOI":"10.1002\/14651858.CD000059"},{"key":"WATSON-AND-MACDONALD-1974","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1974.tb01694.x"},{"key":"WATT-SMITH-ETAL-2001","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2001.115126"},{"key":"WEINTRAUB-ETAL-1992","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.70"},{"key":"WELLINGTON-AND-JARVIS-2001","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161150-00009"},{"key":"WELLINGTON-AND-PERRY-2001","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115080-00007"},{"key":"WESTBURY-AND-NAJERA-1997","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1997.68.1.84"},{"key":"WHITE-ETAL-1986","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1986.01660230113023"},{"key":"WIESENFELD-ETAL-1982","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4804958"},{"key":"WINNER-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02013.x"},{"key":"WISHART-ETAL-1981","unstructured":"Wishart JM, Hodge JL, Greig DE (1981). Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro-10-9359) Tigason. NZ Med J 94:307\u2013308."},{"key":"WOLF-AND-BRENNER-1994","doi-asserted-by":"crossref","unstructured":"Wolf R, Brenner S (1994). An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship? Dermatology 189:1\u20134.","DOI":"10.1159\/000246749"},{"key":"WOLF-AND-RUOCCO-1997","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-9877(97)90277-2"},{"key":"WOLF-ETAL-1991","doi-asserted-by":"publisher","DOI":"10.1159\/000247795"},{"key":"WYNN-AND-MEILLER-2001","unstructured":"Wynn RL, Meiller TF (2001). Drugs and dry mouth. Gen Dent 49:10\u201312, 14."},{"key":"ZACNY-2001","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00186-1"},{"key":"ZINNER-ETAL-2002","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2002.50203.x"},{"key":"ZWAR-AND-RICHMOND-2002","unstructured":"Zwar N, Richmond R (2002). Bupropion sustained release. A therapeutic review of Zyban. Aust Fam Physician 31:443\u2013447."}],"container-title":["Critical Reviews in Oral Biology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/154411130401500405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/154411130401500405","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/154411130401500405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T12:41:27Z","timestamp":1728132087000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/154411130401500405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":327,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1177\/154411130401500405"],"URL":"https:\/\/doi.org\/10.1177\/154411130401500405","relation":{},"ISSN":["1045-4411","1544-1113"],"issn-type":[{"value":"1045-4411","type":"print"},{"value":"1544-1113","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}